Stock 002286 BAOLINGBAO BIOLOGY CO.,LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Baolingbao Biology Co.,Ltd.

Equities

002286

CNE100000FL1

Food Processing

End-of-day quote Shenzhen S.E.
Other stock markets
 06:00:00 2024-04-28 pm EDT 		5-day change 1st Jan Change
6.07 CNY +4.48% Intraday chart for Baolingbao Biology Co.,Ltd. +11.58% -25.25%
Mar. 01 Baolingbao Biology Co.,Ltd. Announces Implementation of Final Cash Dividend for 2023, Payable on 08 March 2024 CI
Feb. 07 Baolingbao Biology Co.,Ltd. Proposes Cash Dividend for 2023 CI

Valuation

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Capitalization 1 2,016 2,223 4,210 5,028 3,380 3,011
Enterprise Value (EV) 1 2,110 2,308 3,970 4,748 3,520 3,072
P/E ratio 45.5 x 60.2 x 81.4 x 24.6 x 25.3 x 54.1 x
Yield 0.55% 0.5% 0.53% 0.44% 0.88% 0.99%
Capitalization / Revenue 1.17 x 1.23 x 2.05 x 1.82 x 1.25 x 1.19 x
EV / Revenue 1.22 x 1.28 x 1.93 x 1.72 x 1.3 x 1.22 x
EV / EBITDA 16.2 x 14.5 x 26.3 x 15.1 x 13.6 x 17.3 x
EV / FCF 45.1 x -34.8 x 12.5 x 69.9 x -9.45 x -99.5 x
FCF Yield 2.22% -2.88% 7.97% 1.43% -10.6% -1.01%
Price to Book 1.31 x 1.42 x 2.63 x 2.77 x 1.69 x 1.52 x
Nbr of stocks (in thousands) 369,256 369,256 369,256 371,912 371,813 370,771
Reference price 2 5.460 6.020 11.40 13.52 9.090 8.120
Announcement Date 4/29/19 4/28/20 4/28/21 4/28/22 4/27/23 2/6/24
1CNY in Million2CNY
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales 1 1,730 1,805 2,055 2,765 2,713 2,524
EBITDA 1 130.1 159.4 151.2 313.6 258 177.6
EBIT 1 46.75 61.62 55.37 213 156.6 59.78
Operating Margin 2.7% 3.41% 2.69% 7.7% 5.77% 2.37%
Earnings before Tax (EBT) 1 52.5 45.79 59.63 236.7 156.7 65.11
Net income 1 42.95 35.23 49.86 201.6 133.2 53.97
Net margin 2.48% 1.95% 2.43% 7.29% 4.91% 2.14%
EPS 2 0.1200 0.1000 0.1400 0.5500 0.3600 0.1500
Free Cash Flow 1 46.79 -66.36 316.6 67.94 -372.4 -30.89
FCF margin 2.7% -3.68% 15.41% 2.46% -13.73% -1.22%
FCF Conversion (EBITDA) 35.97% - 209.36% 21.66% - -
FCF Conversion (Net income) 108.93% - 635% 33.7% - -
Dividend per Share 2 0.0300 0.0300 0.0600 0.0600 0.0800 0.0800
Announcement Date 4/29/19 4/28/20 4/28/21 4/28/22 4/27/23 2/6/24
1CNY in Million2CNY
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt 1 93.5 84.8 - - 141 61.4
Net Cash position 1 - - 239 280 - -
Leverage (Debt/EBITDA) 0.7189 x 0.5318 x - - 0.5452 x 0.3457 x
Free Cash Flow 1 46.8 -66.4 317 67.9 -372 -30.9
ROE (net income / shareholders' equity) 2.78% 2.25% 3.15% 11.8% 6.98% 2.71%
ROA (Net income/ Total Assets) 1.25% 1.51% 1.35% 4.72% 3.24% 1.32%
Assets 1 3,444 2,332 3,700 4,273 4,106 4,092
Book Value Per Share 2 4.170 4.240 4.330 4.880 5.390 5.350
Cash Flow per Share 2 1.130 1.130 1.310 1.570 1.010 0.6500
Capex 1 174 95.5 132 92.8 255 152
Capex / Sales 10.04% 5.29% 6.42% 3.36% 9.38% 6.03%
Announcement Date 4/29/19 4/28/20 4/28/21 4/28/22 4/27/23 2/6/24
1CNY in Million2CNY
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Annual profits - Rate of surprise

Company calendar

Sector Sugar & Artificial Sweeteners

1st Jan change Capi.
BAOLINGBAO BIOLOGY CO.,LTD. Stock Baolingbao Biology Co.,Ltd.
-25.25% 296M
SÜDZUCKER AG Stock Südzucker AG
-6.84% 2.85B
SÃO MARTINHO S.A. Stock São Martinho S.A.
-1.57% 1.9B
COSUMAR SA Stock Cosumar SA
+2.03% 1.84B
ADECOAGRO S.A. Stock Adecoagro S.A.
+0.36% 1.17B
SHREE RENUKA SUGARS LIMITED Stock Shree Renuka Sugars Limited
-3.39% 1.15B
TRIVENI ENGINEERING & INDUSTRIES LIMITED Stock Triveni Engineering & Industries Limited
+7.66% 956M
BALRAMPUR CHINI MILLS LIMITED Stock Balrampur Chini Mills Limited
-2.13% 945M
SHANDONG BAILONG CHUANGYUAN BIO-TECH CO., LTD. Stock Shandong Bailong Chuangyuan Bio-Tech Co., Ltd.
-2.15% 902M
HONGMIAN ZHIHUI SCIENCE AND TECHNOLOGY INNOVATION CO.,LTD.GUANGZHOU Stock Hongmian Zhihui Science and Technology Innovation Co.,Ltd.Guangzhou
-0.32% 780M
Sugar & Artificial Sweeteners
  1. Stock Market
  2. Equities
  3. 002286 Stock
  4. Financials Baolingbao Biology Co.,Ltd.